Allocations
Sixpoint Partners, a global investment bank serving the middle market, has closed Delta-v Capital 2015 with USD232 million raised through limited partner capital commitments and its co-invested fund, Delta-v Capital 2015 Access Fund.
Delta-v Capital closed the fund in excess of its USD150 million target, receiving commitments from a number of top-tier investors, including public pensions, asset managers, family offices and corporate pensions.
Fund III’s strategy is to use Delta-v’s capital and experience to offer liquidity solutions and growth equity to enable private technology companies to realise a higher trajectory of growth and success.
The firm typically invests
The Wood Street Microcap Investment Fund has been renamed as the CF Livingbridge UK Micro Cap Fund.
The changes will align the fund name with that of the investment manager.
Livingbridge is a UK mid-market private equity houses, with a bottom-up investment approach.
The fund continues to invest in growth sectors within the UK economy and in companies that have the potential to increase profits without a tailwind from the wider economy.
Ken Wotton is the lead fund manager of the CF Livingbridge UK Micro Cap Fund and has been since launch in 2009. He leverages the
Private equity fund manager YFM Equity Partners has closed its first buy-out fund, YFMEP 2016, at GBP45 million, 50 per cent above its initial target.
Launched last year, the fund is targeted at the gap left by venture capital trusts; focussing on buy-out and growth investments in the UK requiring equity of up to GBP10 million.
All YFMEP 2016’s investors are UK based, drawn from institutions, families and individuals with the average investment around GBP2.5 million.
With only a few funds targeted at this market, YFM is looking to invest the monies within two years; with a strong
Shore Capital Partners’ product platform IZI Medical Products has acquired the vertebroplasty family of products from Cook Medical.
The acquired products are commercially marketed under the Duro-Ject Osteo-Site, Osteo-Force and Vertefix brands, consisting of needles, injectors and cements.
These products are used in the growing market for treating vertebral compression fractures through a minimally invasive procedure.
“Cook has done an excellent job establishing these products as reliable, high-quality solutions for treating vertebral compression fractures and we have enjoyed working with them on this transaction,” says Greg Groenke, chief executive officer, IZI Medical. “We are excited to increase the
Neology is to acquire the tolling and automated license/number plate recognition business of 3M’s traffic safety and security division.
Neology is a subsidiary of SMARTRAC, a portfolio company managed by One Equity Partners (OEP), a middle-market private equity firm.
The transaction is expected to close by the third quarter of 2017, subject to customary closing conditions, regulatory approvals and consultation or information requirements with relevant works councils. Terms of the private transaction were not disclosed.
The business’s tolling solutions include high-quality RFID readers and tags, automatic vehicle classification systems, lane controller and host software, and back office software
Fintech and payment solutions provider Tuxedo Money Solutions has been acquired by Erik Fällström and Andreas H Tuczka, of Aldridge EDC Specialty Finance Partners (AEDC).
Fällström, former co-founder of HOIST Finance, and Tuczka, former partner at Lone Star Europe, will support Tuxedo CEO John Sharman in delivering the company’s growth plans across Europe and beyond.
With extensive experience within financial services, the new investors will help to drive Tuxedo’s diversification and growth on four fronts: customised, white label card and payment programmes; PayTech platform solutions, centred around Tuxedo’s new Liveload technology; alternative banking services; and expansion into the consumer credit
PineBridge Investments, a global multi-asset class asset manager, has launched the PineBridge European Secured Credit Fund, co-managed by portfolio managers Julie Bothamley and Evangeline Lim and global head of credit and fixed income Steven Oh.
The investment objective of the fund is to provide investors with income returns and capital preservation from a diversified portfolio of European sub-investment grade debt obligations issued by corporations in various industries and geographical regions.
The fund will seek to achieve these returns from investing in primarily senior secured obligations.
“Senior secured debt, particularly, bank loans, carry a higher recovery rate and rank
Independent fund research company Fitz Partners gives an insight into the calculations of funds’ performance fees and their choice of benchmarks in the latest edition of its Performance Fee Benchmarking Report and Database.
Hugues Gillibert (pictured), chief executive officer of Fitz Partners, says: “In light of growing discussions on how asset managers should be charging for ‘value’ and the alignment of investors and fund managers’ interests through the possible development of performance related fees, a deep understanding of performance fee structures is critical. Our latest Performance Fee Benchmarking report and database, offers the means to easily compare and analyse different performance
Morrison Street Capital’s Morrison Street Debt Opportunities Fund (MSDO) has reached its target with total equity commitments of USD200 million.
MSDO provides small-balance mezzanine capital, with investment balances generally ranging from USD2 million to USD10 million, to real estate market participants across a diversified set of property types in the top 100 MSAs nationwide.
MSDO’s investments are structured as either mezzanine debt, B-notes or preferred equity, tailored to meet the specific needs of each situation.
Morrison Street Capital formed MSDO to capitalise on the current opportunity in the debt capital markets, as well as to leverage its experience
Surgery Partners is to merge with National Surgical Healthcare (NSH) after acquiring the company from Irving Place Capital for approximately USD760 million.
Funding for Surgery Partners’ acquisition of NSH will be provided in part by Bain Capital Private Equity, who as part of the transaction, is injecting capital in exchange for a preferred security in the company.
In conjunction with this transaction, Bain Capital Private Equity will acquire HIG Capital’s existing equity stake in Surgery Partners.
The transaction builds upon each company’s physician-centric services model. It creates a diversified inpatient and outpatient surgical provider with a portfolio of
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
